| |
| |
|
| Insider
Information: |
Ragosa Mark |
| Relationship: |
|
| City: |
Hamilton |
| State: |
D0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
19,253 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$376,011 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,253 |
|
|
| Total
Value |
$376,011 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-26 |
19,253 |
2020-12-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-26 |
4 |
D |
$17.88 |
$9,101 |
D/D |
(509) |
19,253 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
991 |
19,762 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-08 |
4 |
D |
$17.90 |
$14,159 |
D/D |
(791) |
18,771 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,694 |
19,562 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-01 |
4 |
D |
$19.70 |
$10,126 |
D/D |
(514) |
16,868 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
17,382 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-01-03 |
4 |
OE |
$8.83 |
$105,960 |
D/D |
12,000 |
27,632 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-01-03 |
4 |
AS |
$20.00 |
$240,000 |
D/D |
(12,000) |
15,632 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-09-02 |
4 |
D |
$17.76 |
$9,715 |
D/D |
(547) |
15,632 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,861 |
16,179 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-09-01 |
4 |
D |
$17.76 |
$14,048 |
D/D |
(791) |
14,318 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,695 |
15,109 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-04-26 |
4 |
D |
$11.15 |
$3,245 |
D/D |
(291) |
12,414 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
990 |
12,705 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-04-10 |
4 |
D |
$10.71 |
$8,472 |
D/D |
(791) |
11,715 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,695 |
12,506 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-03-20 |
4 |
D |
$11.12 |
$7,050 |
D/D |
(634) |
9,811 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,158 |
10,445 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-03-16 |
4 |
D |
$11.46 |
$2,934 |
D/D |
(256) |
8,287 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
872 |
8,543 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2022-09-02 |
4 |
D |
$11.44 |
$6,258 |
D/D |
(547) |
7,671 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2022-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,861 |
8,218 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2022-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
991 |
6,639 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2022-04-26 |
4 |
D |
$9.99 |
$2,817 |
D/D |
(282) |
6,357 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF FINANCIAL OFFICER |
• – – |
2022-03-21 |
4 |
D |
$10.98 |
$11,496 |
D/D |
(1,047) |
5,648 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
